Literature DB >> 26587320

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Silvio Däster1, Serenella Eppenberger-Castori2, Christian Hirt1, Savas D Soysal1, Tarik Delko3, Christian A Nebiker1, Benjamin Weixler3, Francesca Amicarella4, Giandomenica Iezzi4, Valeria Governa4, Elisabetta Padovan4, Valentina Mele4, Giuseppe Sconocchia5, Michael Heberer4, Luigi Terracciano2, Christoph Kettelhack3, Daniel Oertli3, Giulio C Spagnoli4, Urs von Holzen6, Luigi Tornillo2, Raoul A Droeser1.   

Abstract

Colorectal cancer (CRC) infiltration by cells expressing myeloperoxidase (MPO) or CD8 positive T lymphocytes has been shown to be independently associated with favorable prognosis. We explored the relationship occurring between CD8+ and MPO+ cell CRC infiltration, its impact on clinical-pathological features and its prognostic significance in a tissue microarray (TMA) including 1,162 CRC. We observed that CRC showing high MPO+ cell infiltration are characterized by a prognosis as favorable as that of cancers with high CD8+ T cell infiltration. However, MPO+ and CD8+ CRC infiltrating cells did not synergize in determining a more favorable outcome, as compared with cancers showing MPOhigh/CD8low or MPOlow/CD8high infiltrates. Most importantly, we identified a subgroup of CRC with MPOlow/CD8low tumor infiltration characterized by a particularly severe prognosis. Intriguingly, although MPO+ and CD8+ cells did not co-localize in CRC infiltrates, an increased expression of TIA-1 and granzyme-B was detectable in T cells infiltrating CRC with high MPO+ cell density.

Entities:  

Keywords:  CD8+; human colorectal cancer; myeloperoxidase; prognostic markers; tissue microarray

Year:  2015        PMID: 26587320      PMCID: PMC4635694          DOI: 10.1080/2162402X.2015.1050574

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  39 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

4.  Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines.

Authors:  Niels Halama; Monika Braun; Christoph Kahlert; Anna Spille; Christian Quack; Nuh Rahbari; Moritz Koch; Jürgen Weitz; Matthias Kloor; Inka Zoernig; Peter Schirmacher; Karsten Brand; Niels Grabe; Christine S Falk
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

5.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

6.  Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.

Authors:  Massimo Pancione; Nicola Forte; Lina Sabatino; Eugenio Tomaselli; Domenico Parente; Antonio Febbraro; Vittorio Colantuoni
Journal:  Hum Pathol       Date:  2009-01-03       Impact factor: 3.466

7.  GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.

Authors:  Christian A Nebiker; Junyi Han; Serenella Eppenberger-Castori; Giandomenica Iezzi; Christian Hirt; Francesca Amicarella; Eleonora Cremonesi; Xaver Huber; Elisabetta Padovan; Basilio Angrisani; Raoul A Droeser; Raffaele Rosso; Martin Bolli; Daniel Oertli; Urs von Holzen; Michel Adamina; Manuele G Muraro; Chantal Mengus; Paul Zajac; Giuseppe Sconocchia; Markus Zuber; Luigi Tornillo; Luigi Terracciano; Giulio C Spagnoli
Journal:  Clin Cancer Res       Date:  2014-04-15       Impact factor: 12.531

8.  Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis.

Authors:  Hui-Lan Rao; Jie-Wei Chen; Mei Li; Yong-Bo Xiao; Jia Fu; Yi-Xin Zeng; Mu-Yan Cai; Dan Xie
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

Review 9.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

10.  Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.

Authors:  M P Colombo; G Ferrari; A Stoppacciaro; M Parenza; M Rodolfo; F Mavilio; G Parmiani
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  12 in total

1.  Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer.

Authors:  Armin Jarosch; Ulrich Sommer; Andreas Bogner; Christoph Reißfelder; Jürgen Weitz; Mechthild Krause; Gunnar Folprecht; Gustavo B Baretton; Daniela E Aust
Journal:  Oncoimmunology       Date:  2017-11-07       Impact factor: 8.110

Review 2.  Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Authors:  Evgeniy B Eruslanov; Sunil Singhal; Steven M Albelda
Journal:  Trends Cancer       Date:  2017-01-19

3.  Myeloperoxidase expression in human colonic mucosa is related to systemic oxidative balance in healthy subjects.

Authors:  Stefano Mancini; Francesco Mariani; Paola Sena; Marta Benincasa; Luca Roncucci
Journal:  Redox Rep       Date:  2017-01-09       Impact factor: 4.412

4.  Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.

Authors:  Valerio Nardone; Cirino Botta; Michele Caraglia; Elodia Claudia Martino; Maria Raffaella Ambrosio; Tommaso Carfagno; Paolo Tini; Leonardo Semeraro; Gabriella Misso; Anna Grimaldi; Mariarosaria Boccellino; Gaetano Facchini; Massimiliano Berretta; Gianluca Vischi; Bruno Jim Rocca; Aurora Barone; Pierfrancesco Tassone; Pierosandro Tagliaferri; Maria Teresa Del Vecchio; Luigi Pirtoli; Pierpaolo Correale
Journal:  Cancer Biol Ther       Date:  2016-11       Impact factor: 4.742

5.  Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.

Authors:  Yiyin Zhang; Hongyang Wu; Feng Yang; Jie Ning; Min Li; Chenchen Zhao; Shuping Zhong; Kangsheng Gu; Hua Wang
Journal:  Am J Pathol       Date:  2018-01-10       Impact factor: 4.307

6.  Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer.

Authors:  Hao Li; Kamala Vanarsa; Ting Zhang; Sanam Soomro; Pietro Antonio Cicalese; Valeria Duran; Shobha Dasari; Kyung Hyun Lee; Claudia Pedroza; John B Kisiel; Huanlong Qin; Robert S Bresalier; Nicholas Chia; Chandra Mohan
Journal:  J Gastroenterol       Date:  2021-06-12       Impact factor: 7.527

7.  Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.

Authors:  Alexandros Lalos; Ali Tülek; Nadia Tosti; Robert Mechera; Alexander Wilhelm; Savas Soysal; Silvio Daester; Venkatesh Kancherla; Benjamin Weixler; Giulio C Spagnoli; Serenella Eppenberger-Castori; Luigi Terracciano; Salvatore Piscuoglio; Markus von Flüe; Alberto Posabella; Raoul A Droeser
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

8.  Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.

Authors:  Jie You; Gui-Qi Zhu; Linka Xie; Wen-Yue Liu; Liang Shi; Ou-Chen Wang; Zong-Hai Huang; Martin Braddock; Gui-Long Guo; Ming-Hua Zheng
Journal:  Oncotarget       Date:  2016-05-03

9.  Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage.

Authors:  Mark A Glaire; Enric Domingo; Anita Sveen; Jarle Bruun; Arild Nesbakken; George Nicholson; Marco Novelli; Kay Lawson; Dahmane Oukrif; Wanja Kildal; Havard E Danielsen; Rachel Kerr; David Kerr; Ian Tomlinson; Ragnhild A Lothe; David N Church
Journal:  Br J Cancer       Date:  2019-08-07       Impact factor: 7.640

10.  An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.

Authors:  Yanfei Shao; Hongtao Jia; Ling Huang; Shuchun Li; Chenxing Wang; Batuer Aikemu; Guang Yang; Hiju Hong; Xiao Yang; Sen Zhang; Jing Sun; Minhua Zheng
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.